IMUGENE LIMITED - Charts / Financials

Market Cap $607.5M Add to my watchlist

Healthcare Biotechnology

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing... Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs. More

BlinkLab Limited (ASX: BB1) is a trailblazer in digital healthcare, leveraging AI and machine learning in mobile applications to revolutioniSe neurodevelopmental condition diagnosis like ASD and ADHD. Born from extensive research at Princeton University,...

REFRESH

Last update - 15.59pm 25/04/2024 (20 minute delay)

Day
Open	8.4¢		Day High	8.5¢		Day Low	8.2¢
Daily Volume	11486774

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
1	8.3¢	40556		4	8.4¢	216619

Directors & Senior Management

Mr. Paul E. Hopper	Executive Chairman of the Board
Ms. Leslie Chong	Chief Executive Officer, Managing Director, Executive Director
Mr. Michael Tonroe	Chief Financial Officer, Company Secretary
Dr. Bradley Glover	Chief Operating Officer
Dr. Nicholas Ede	Chief Technology Officer
Dr. Monil Shah	Chief Business Officer
Dr. Paul Woodard	Chief Medical Officer
Ms. Kimberlee Cobleigh Drapkin	Non-Executive Independent Director
Dr. Jakob Dupont	Non-Executive Independent Director
Dr. Jens W. Eckstein	Non-Executive Independent Director
Dr. Lesley Russell	Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last 8.3¢		Change -0.002(2.35%)		Mkt cap ! $607.5M

Open	High	Low	Value	Volume
8.4¢	8.5¢	8.2¢	$953.1K	11.48M

Buyers (Bids)

No.	Vol.	Price($)
1	40556	8.3¢

Sellers (Offers)

Price($)	Vol.	No.
8.4¢	216619	4

View Market Depth

No.	Vol.	Price($)
1	40556	0.083
7	636950	0.082
13	900677	0.081
19	1013939	0.080
6	1116714	0.079

Price($)	Vol.	No.
0.084	216619	4
0.085	78430	2
0.086	1000000	3
0.087	961557	9
0.088	700000	2

Last trade - 16.10pm 25/04/2024 (20 minute delay)


Last 8.4¢		Change -0.002 ( 1.42 %)
Open	High	Low	Volume
8.4¢	8.5¢	8.2¢	6636401
Last updated 15.59pm 25/04/2024 ?

IMU (ASX) Chart

IMUGENE LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories